Cargando…

Carboplatin and renal function in children.

Detalles Bibliográficos
Autores principales:	Stevens, M. C., Lewis, I. J., Pearson, A. J., Pinkerton, C. R.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1991
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971627/ https://www.ncbi.nlm.nih.gov/pubmed/1989658

Ejemplares similares

How nephrotoxic is carboplatin?
por: Hardy, J. R., et al.
Publicado: (1990)

'JEB'--a carboplatin based regimen for malignant germ cell tumours in children.
por: Pinkerton, C. R., et al.
Publicado: (1990)

Dose-related nephrotoxicity of carboplatin in children
por: English, M W, et al.
Publicado: (1999)

Estimation of renal function and its potential impact on carboplatin dosing in children with cancer
por: Chinnaswamy, G, et al.
Publicado: (2008)

Acute and cumulative effects of carboplatin on renal function.
por: Sleijfer, D. T., et al.
Publicado: (1989)

The effect of carboplatin on renal function in patients with metastatic germ cell tumours.
por: Mason, M. D., et al.
Publicado: (1991)

Comment on ‘The efficacy and toxicity of gemcitabine, carboplatin and bevacizumab in metastatic breast cancer‘
por: Kitchen, D, et al.
Publicado: (2013)

Rechallenge to Carboplatin in Children with Low Grade Glioma and Carboplatin Hypersensitivity Reactions
por: Ruggiero, Antonio, et al.
Publicado: (2017)

Adaptive dosing and platinum–DNA adduct formation in children receiving high-dose carboplatin for the treatment of solid tumours
por: Veal, G J, et al.
Publicado: (2007)

Hypersensitivity to Carboplatin in Children with Malignancy
por: Ruggiero, Antonio, et al.
Publicado: (2017)

Platinum-DNA adduct formation in leucocytes of children in relation to pharmacokinetics after cisplatin and carboplatin therapy.
por: Peng, B., et al.
Publicado: (1997)

A randomised study comparing standard dose carboplatin with chlorambucil and carboplatin in advanced ovarian cancer.
por: Rankin, E. M., et al.
Publicado: (1992)

Carboplatin binding to histidine
por: Tanley, Simon W. M., et al.
Publicado: (2014)

High-dose therapy including carboplatin adjusted for renal function in patients with relapsed or refractory germ cell tumour: outcome and prognostic factors.
por: Lyttelton, M. P., et al.
Publicado: (1998)

Modified protocol of omalizumab treatment to prevent carboplatin-induced drug hypersensitivity reactions: a case study
por: Oude Elberink, Hanneke N. G., et al.
Publicado: (2020)

Carboplatin Dosing in Children Using Estimated Glomerular Filtration Rate: Equation Matters
por: van de Velde, Mirjam E., et al.
Publicado: (2021)

A Case of Metastatic Basosquamous Basal Cell Carcinoma Treated With Carboplatin and Paclitaxel
por: Papageorgiou, Chryssoula, et al.
Publicado: (2023)

Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis.
por: English, M. W., et al.
Publicado: (1996)

Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity
por: Helbekkmo, N, et al.
Publicado: (2007)

Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients
por: Wagner, U, et al.
Publicado: (2012)

Comparison of Renal Functions Evaluated by Measured Glomerular Filtration Rate in Patients Treated With Cisplatin, Carboplatin, and Oxaliplatin
por: Choudhary, Rajnee, et al.
Publicado: (2023)

A phase I and pharmacokinetic study of indisulam in combination with carboplatin
por: Dittrich, C, et al.
Publicado: (2007)

A randomised study of carboplatin vs sequential ifosfamide/carboplatin for patients with FIGO stage III epithelial ovarian carcinoma. The London Gynaecologic Oncology Group.
por: Perren, T. J., et al.
Publicado: (1993)

A case of recurrent malignant fibrous histiocytoma with marked response to combined chemotherapy with gemcitabine and carboplatin
por: Wei, Zhang, et al.
Publicado: (2014)

Carboplatin dose based on actual renal function: no excess of acute haematotoxicity in adjuvant treatment in seminoma stage I
por: Fehr, Martin, et al.
Publicado: (2018)

Formation of interaction products of carboplatin with DNA in vitro and in cancer patients.
por: Terheggen, P. M., et al.
Publicado: (1991)

Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group.
por: Estlin, E. J., et al.
Publicado: (1998)

Haematological toxicity of carboplatin in rats.
por: Siddik, Z. H., et al.
Publicado: (1987)

Cisplatin/carboplatin cross-resistance in ovarian cancer.
por: Gore, M. E., et al.
Publicado: (1989)

Whole body hyperthermia and carboplatin: cytotoxicity for murine leukaemia and normal marrow.
por: Tapazoglou, E., et al.
Publicado: (1991)

Application of prolonged microdialysis sampling in carboplatin-treated cancer patients
por: Konings, Inge R. H. M., et al.
Publicado: (2008)

Transcatheter Arterial Embolization of Renal VX-2 Carcinoma: Ethiodol-Ethanol Capillary Embolization Combined with Carboplatin
por: Kónya, András, et al.
Publicado: (2007)

Reduction of carboplatin induced emesis by ondansetron.
por: Harvey, V. J., et al.
Publicado: (1991)

Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats.
por: Ohno, S., et al.
Publicado: (1993)

Concurrent chemoradiotherapy with carboplatin followed by carboplatin and 5- fluorouracil in locally advanced nasopharyngeal carcinoma
por: Dechaphunkul, Tanadech, et al.
Publicado: (2011)

Recruiting children into cancer trials–role of the United Kingdom Children's Cancer Study Group (UKCCSG)
por: Ablett, S, et al.
Publicado: (2003)

More on hypertension and reduced renal function
por: La Regina, M., et al.
Publicado: (2007)

Cancer in Children. Clinical Management. 3rd Edition
por: Pinkerton, C.R.
Publicado: (1993)

1,5-Asymmetric induction during nucleophilic additions to arenetricarbonylchromium complexes: tricarbonyl(η(6)-1-methyl-4-{spiro[(1R,2S)-1,7,7-trimethylbicyclo[2.2.1]heptane-3,2′-1,3-dioxolan]-2-yloxy}benzene)chromium
por: Paramahamsan, Harinandini, et al.
Publicado: (2008)

Carboplatin-Induced Hypersensitivity Reaction
por: Potolidis, Evangelos, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_mo3b5ga80qq2bjbb8s957clnoj